Biological products
-
Subject Areas on Research
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
- A comparison of moment-based and probability-based criteria for assessment of follow-on biologics.
- A comprehensive review of topical hemostatic agents: efficacy and recommendations for use.
- A general strategy for construction of both 2,6-cis- and 2,6-trans-disubstituted tetrahydropyrans: substrate-controlled asymmetric total synthesis of (+)-scanlonenyne.
- ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee.
- Absence of macrophage involvement in the passive serum therapy of Friend leukemia virus-induced disease.
- Advances in Wound Management.
- Advances in the synthesis of glycosidic macrolides: clavosolides A-D and cyanolide A.
- Advances in the treatment of inflammatory arthritis.
- An overview of naturally occurring histone deacetylase inhibitors.
- Anisotropic wetting surfaces with one-dimensional and directional structures: fabrication approaches, wetting properties and potential applications.
- Application of the parallel line assay to assessment of biosimilar products based on binary endpoints.
- Biologics in organ transplantation.
- C-C bond forming radical SAM enzymes involved in the construction of carbon skeletons of cofactors and natural products.
- Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma.
- Catalytic enantioselective alkylation of substituted dioxanone enol ethers: ready access to Calpha-tetrasubstituted hydroxyketones, acids, and esters.
- Catalytic enantioselective olefin metathesis in natural product synthesis. Chiral metal-based complexes that deliver high enantioselectivity and more.
- Clinical Features and Treatment of Down Syndrome Arthropathy: Experience from Two US Tertiary Hospitals.
- Clinical Improvements in Very Dry Skin from a Natural Ingredient-Based Moisturizing Cream Compared With a Leading Colloidal Oatmeal Control.
- Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis.
- Comparative effectiveness of surfactant preparations in premature infants.
- Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions.
- Controlled release of biologics for the treatment of type 2 diabetes.
- Decreased use of non-steroidal anti-inflammatory drugs for the treatment of juvenile idiopathic arthritis in the era of modern aggressive treatment.
- Design and stereoselective preparation of a new class of chiral olefin metathesis catalysts and application to enantioselective synthesis of quebrachamine: catalyst development inspired by natural product synthesis.
- Design considerations, architecture, and use of the Mini-Sentinel distributed data system.
- Discovery of Manassantin A Protein Targets Using Large-Scale Protein Folding and Stability Measurements.
- Effect of pulmonary surfactant on the dissolution, stability and uptake of zinc oxide nanowires by human respiratory epithelial cells.
- Evaluation of the Performance of a Nature-Based Sensitive Skin Regimen in Subjects With Clinically Diagnosed Sensitive Skin.
- Formal Synthesis of (+)-Laurencin by Gold(I)-Catalyzed Intramolecular Dehydrative Alkoxylation.
- Genomic strategies for personalized cancer therapy.
- Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies.
- Largazole: from discovery to broad-spectrum therapy.
- Microglassification™: a novel technique for protein dehydration.
- Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.
- Natural Skin Care Products as Adjunctive to Prescription Therapy in Moderate to Severe Rosacea
- Natural product synthesis at the interface of chemistry and biology.
- New and Pipeline Drugs for Gout.
- Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment.
- Perfluorooctyl bromide (perflubron) attenuates oxidative injury to biological and nonbiological systems.
- Prescription patterns for children with juvenile idiopathic arthritis in Michigan Medicaid: a comparison by prescriber type.
- Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016.
- Radical Breakthroughs in Natural Product and Cofactor Biosynthesis.
- Reply to Vanhove et al.
- Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.
- Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality Improvement.
- Role of natural product diversity in chemical biology.
- Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.
- Static and Dynamic Microscopy of the Chemical Stability and Aggregation State of Silver Nanowires in Components of Murine Pulmonary Surfactant.
- Statistical and regulatory considerations in assessments of interchangeability of biological drug products.
- Statistical assessment of biosimilar products.
- Statistical methods for assessment of biosimilarity using biomarker data.
- Statistical test for evaluation of biosimilarity in variability of follow-on biologics.
- Synthesis of α,α'-trans-oxepanes through an organocatalytic oxa-conjugate addition reaction.
- Synthetic efforts towards the stereoselective synthesis of NF00659B1.
- Systematic assignment of the configuration of flexible natural products by spectroscopic and computational methods: the bistramide C analysis.
- Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions.
- The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.
- The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.
- The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.
- The impact of specialty pharmaceuticals as drivers of health care costs.
- Therapy of rheumatoid arthritis: new developments and trends.
- There is a role for industry-sponsored education in cardiology.
- Three-dimensional reconstruction of tubular myelin.
- Tides of inflammation: impact of biologics.
- Total synthesis of (-)-hennoxazole A.
- Treatment of juvenile idiopathic arthritis-associated uveitis: challenges and update.
- Using Medicare administrative data to conduct postmarketing surveillance of follow-on biologics: issues and opportunities.
- Using registries to identify adverse events in rheumatic diseases.
- Ventricular assist devices and increased blood product utilization for cardiac transplantation.
- What's next in the pipeline.
-
Keywords of People
- Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
- Stinnett, Sandra Sue, Associate Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics